US29415V1098
© Newsfile
10.12.2025
FEED
LISTED
NASDAQ
Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant
News Preview
Momentum continues to build for Company as series of clinical milestones are met, design choices cement differentiation from competition, and timeline comes into focusWhite Bear Lake, Minnesota--(Newsfile Corp. - December 10, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering full...
Themefolio
Profiler
Peergroup
© Newsfile
04.12.2025
FEED
LISTED
NASDAQ
Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient
News Preview
Event to Take Place December 11th at 4:30 P.M. ETWhite Bear Lake, Minnesota--(Newsfile Corp. - December 4, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that it will host a fireside chat on Thursday, December 11, 2025, at 4:3...
Themefolio
Profiler
Peergroup
© Newsfile
02.12.2025
FEED
LISTED
NASDAQ
Envoy Medical Announces the Grant of Its 40th U.S. Patent
News Preview
New Patent Adds to Company's Growing Portfolio of Intellectual Property Focused on Fully Implanted Hearing DevicesWhite Bear Lake, Minnesota--(Newsfile Corp. - December 2, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that it...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Newsfile
20.11.2025
FEED
LISTED
NASDAQ
Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery
News Preview
Patent adds to Envoy Medical's expanding intellectual property portfolio, reinforcing the Company's leadership in next generation cochlear implant innovationWhite Bear Lake, Minnesota--(Newsfile Corp. - November 20, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneerin...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Newsfile
18.11.2025
FEED
LISTED
NASDAQ
Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial
News Preview
The trials expansion highlights the Company's clinical momentum and growing confidence in the device's adoption and Company's commercial strategyWhite Bear Lake, Minnesota--(Newsfile Corp. - November 18, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing so...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
FEED
LISTED
NASDAQ
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results
News Preview
Transformational quarter puts Envoy Medical in significantly better position as it eliminated $32 million of debt, strengthened its balance sheet, and further expanded its patent portfolio; In addition, subsequent to quarter end, the Company received FDA approval to expand its pivotal clinical trial to the final stage, restarted enrollment, and suc...
Themefolio
Profiler
Peergroup
© Newsfile
04.11.2025
FEED
LISTED
NASDAQ
Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial
News Preview
Rapid patient enrollment underscores strong market interest and reinforces commercialization opportunity for fully implanted cochlear implantsWhite Bear Lake, Minnesota--(Newsfile Corp. - November 4, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions,...
Themefolio
Profiler
Peergroup
© Newsfile
29.10.2025
FEED
LISTED
NASDAQ
Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant
News Preview
The Company looks to build on its recent momentum - receiving FDA approval to expand its pivotal clinical trial into the second and final stageWhite Bear Lake, Minnesota--(Newsfile Corp. - October 29, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions,...
Themefolio
Profiler
Peergroup
© Newsfile
27.10.2025
FEED
LISTED
NASDAQ
Envoy Medical Receives Positive Listing Determination from NASDAQ
News Preview
White Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that the Nasdaq Hearings Panel (the "Panel) has granted the Company's request for continued listing on the Nasdaq Stock Market...
Themefolio
Profiler
Peergroup
© Newsfile
09.10.2025
FEED
LISTED
NASDAQ
Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
News Preview
$4 million upfront with up to additional $12 million of potential aggregate gross proceeds upon the exercise in full of warrantsWhite Bear Lake, Minnesota--(Newsfile Corp. - October 9, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, toda...
Themefolio
Profiler
Peergroup
© Newsfile
08.10.2025
FEED
LISTED
NASDAQ
Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
News Preview
$4 million upfront with up to additional $12 million of potential aggregate gross proceeds upon the exercise in full of warrantsWhite Bear Lake, Minnesota--(Newsfile Corp. - October 8, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, toda...
Themefolio
Profiler
Peergroup
© Newsfile
07.10.2025
FEED
LISTED
NASDAQ
Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data
News Preview
The Company expects to complete full enrollment by early 2026 and is moving its timelines up three to six months, cutting its anticipated capital needs by $10-$15 millionWhite Bear Lake, Minnesota--(Newsfile Corp. - October 7, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully im...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
01.10.2025
FEED
LISTED
NASDAQ
Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th
News Preview
White Bear Lake, Minnesota--(Newsfile Corp. - October 1, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced that management will participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) conferen...
Themefolio
Profiler
Peergroup
© Newsfile
25.09.2025
FEED
LISTED
NASDAQ
Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
News Preview
White Bear Lake, Minnesota--(Newsfile Corp. - September 25, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 1,9...
Themefolio
Profiler
Peergroup
© Newsfile
24.09.2025
FEED
LISTED
NASDAQ
Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track
News Preview
The Company Begins Strategic Preparations To Support Anticipated Demand And Optimization Of The Acclaim® Fully Implanted Cochlear Implant OpportunitySix-month follow-up visits are now underway and will continue over the next two monthsWhite Bear Lake, Minnesota--(Newsfile Corp. - September 24, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("...
Themefolio
Profiler
Peergroup
© Newsfile
22.09.2025
FEED
LISTED
NASDAQ
Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
News Preview
White Bear Lake, Minnesota--(Newsfile Corp. - September 22, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced it has entered into a definitive agreement for the issuance and sale of an aggregate of 1,908,402 shares of its C...
Themefolio
Profiler
Peergroup
© Newsfile
19.09.2025
FEED
LISTED
NASDAQ
Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology
News Preview
Patent covers advanced signal processing for middle ear sensors, further advancing the Company's position in leveraging the ear for fully implanted hearing devicesWhite Bear Lake, Minnesota--(Newsfile Corp. - September 19, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, f...
Themefolio
Profiler
Peergroup
© Newsfile
10.09.2025
FEED
LISTED
NASDAQ
Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments
News Preview
Highlights include Expanded Global Patent Portfolio, Complete Debt Elimination Strengthening Balance Sheet, and Further Momentum of Pivotal Clinical TrialWhite Bear Lake, Minnesota--(Newsfile Corp. - September 10, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully impl...
Themefolio
Profiler
Peergroup
© Newsfile
09.09.2025
FEED
LISTED
NASDAQ
Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology
News Preview
Patents strengthen Envoy Medical's innovation pipeline and protect next-generation cochlear implant solutions for individuals living with hearing loss.White Bear Lake, Minnesota--(Newsfile Corp. - September 9, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implante...
Themefolio
Profiler
Peergroup
© Newsfile
08.09.2025
FEED
LISTED
NASDAQ
Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025
News Preview
White Bear Lake, Minnesota--(Newsfile Corp. - September 8, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced today announced that Brent Lucas, Envoy Medical's Chief Executive Officer, will present virtually at the H.C. Wain...
Themefolio
Profiler
Peergroup
© Newsfile
03.09.2025
FEED
LISTED
NASDAQ
Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant
News Preview
No Serious Adverse Events or Unanticipated Device Effects Reported; Company Confirms Program Remains On TrackWhite Bear Lake, Minnesota--(Newsfile Corp. - September 3, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted technologies, today announced that the p...
Themefolio
Profiler
Peergroup
© Newsfile
26.08.2025
FEED
LISTED
NASDAQ
Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board
News Preview
Extinguishment simplifies capital structure, strengthens foundation for growth, and eliminates all term loan obligations, without equity conversionWhite Bear Lake, Minnesota--(Newsfile Corp. - August 26, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully impl...
Themefolio
Profiler
Peergroup
© Newsfile
20.08.2025
FEED
LISTED
NASDAQ
Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology
News Preview
Patents issued in the U.S., Australia, and Hong Kong advance Envoy Medical's innovation pipeline and protect next-generation cochlear implant solutions for individuals living with hearing loss.White Bear Lake, Minnesota--(Newsfile Corp. - August 20, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused...
Themefolio
Profiler
Peergroup
© Newsfile
31.07.2025
FEED
LISTED
NASDAQ
Envoy Medical Reports on Second Quarter 2025 Results
News Preview
White Bear Lake, Minnesota--(Newsfile Corp. - July 31, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices, today announced its corporate and financial results for the second quarter ended June 30, 2025, as well as other subsequent events.Financial and...
Themefolio
Profiler
Peergroup
© Newsfile
08.07.2025
FEED
LISTED
NASDAQ
Envoy Medical Expands Patent Portfolio with New Issuances in the United States
News Preview
White Bear Lake, Minnesota--(Newsfile Corp. - July 8, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced the issuance of two new patents, further strengthening its intellectual property portfolio in the United States.The U.S...
Themefolio
Profiler
Peergroup
© Newsfile
01.07.2025
FEED
LISTED
NASDAQ
Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia
News Preview
White Bear Lake, Minnesota--(Newsfile Corp. - July 1, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced the issuance of three new patents, further strengthening its intellectual property portfolio in Australia.The Australia...
Themefolio
Profiler
Peergroup
© Newsfile
26.06.2025
FEED
LISTED
NASDAQ
New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for Envoy Medical
News Preview
The Esteem(R) device by Envoy Medical is the only totally implantable active middle ear implant with FDA Approval currently on the marketWhite Bear Lake, Minnesota--(Newsfile Corp. - June 26, 2025) - Envoy Medical, Inc. (NASDAQ: COCH), a revolutionary hearing health company focused on fully implanted hearing devices that leverage the ear's natural...
Themefolio
Profiler
Peergroup
© Newsfile
10.06.2025
FEED
LISTED
NASDAQ
Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up
News Preview
Positive momentum from the trial's first stage encouraging Company to accelerate plans for expansion and commercializationWhite Bear Lake, Minnesota--(Newsfile Corp. - June 10, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices that leverage the ear's...
Themefolio
Profiler
Peergroup
© Newsfile
13.05.2025
FEED
LISTED
NASDAQ
Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial
News Preview
White Bear Lake, Minnesota--(Newsfile Corp. - May 13, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices that leverage the ear's natural anatomy, today announces achieving the important milestone of successful activation of all 10 study participants'...
Themefolio
Profiler
Peergroup
© Newsfile
01.05.2025
FEED
LISTED
NASDAQ
Envoy Medical Reports on First Quarter 2025 Results
News Preview
Company Provides Update on Its Pivotal Clinical Study for Fully Implanted Cochlear ImplantWhite Bear Lake, Minnesota--(Newsfile Corp. - May 1, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices, today announced its corporate and financial results for...
Themefolio
Profiler
Peergroup
© Newsfile
31.03.2025
FEED
LISTED
NASDAQ
Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results
News Preview
Company Provides Corporate Update that Includes Information on its Progress Enrolling Subjects in its Pivotal Clinical Study for Breakthrough Device, the Fully Implanted Acclaim® Cochlear ImplantWhite Bear Lake, Minnesota--(Newsfile Corp. - March 31, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing he...
Themefolio
Profiler
Peergroup
© Newsfile
12.03.2025
FEED
LISTED
NASDAQ
Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device
News Preview
Billionaire Entrepreneur Glen Taylor, the Company's Largest Shareholder, Continues to Invest Significant Capital into the Company Furthering Its ProgressWhite Bear Lake, Minnesota--(Newsfile Corp. - March 12, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing...
Themefolio
Profiler
Peergroup
© Newsfile
10.03.2025
FEED
LISTED
NASDAQ
Envoy Medical to Participate in the 37th Annual ROTH Conference
News Preview
White Bear Lake, Minnesota--(Newsfile Corp. - March 10, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices, today announced that it will participate in the 37th Annual ROTH Conference being held on March 16 - 18, 2025 at the Laguna Cliffs Marriott Res...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.11.2024
FEED
LISTED
NASDAQ
Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events
News Preview
FDA approval to begin pivotal trial of fully implanted cochlear implant and AMA approval of CPT codes for the Company’s already FDA-approved fully implanted middle ear implant are two of the exciting developments for the growing company FDA approval to begin pivotal trial of fully implanted cochlear implant and AMA approval of CPT codes for the Com...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2024
FEED
LISTED
NASDAQ
Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication
News Preview
Study in Otology & Neurotology outlines early experiences and potential benefits of breakthrough fully implanted cochlear implant...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2024
FEED
LISTED
NASDAQ
Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System
News Preview
WHITE BEAR LAKE, Minnesota, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on fully implanted hearing systems, today announces that the European Patent Office has granted the Company Patent No. 3858425, titled,” Implantable Modular Cochlear Implant System with Communicat...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.11.2024
FEED
LISTED
NASDAQ
Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device
News Preview
The Acclaim® Fully Implanted Cochlear Implant is differentiated from existing cochlear implants and may offer new option for hearing loss patients...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2024
FEED
LISTED
NASDAQ
Envoy Medical to Present at the LD Micro Main Event XVII
News Preview
WHITE BEAR LAKE, Minnesota, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on fully implanted hearing systems, today announced that David R. Wells, Chief Financial Officer, will present a corporate overview at the LD Micro Main Event XVII. The conference is being held on...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.09.2024
FEED
LISTED
NASDAQ
Major Envoy Medical Investor Glen Taylor Discusses How Apple’s AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company
News Preview
During “The Claman Countdown,” the billionaire investor and entrepreneur noted how hearing aid modes in next-gen wireless earbuds can work with Envoy Medical’s fully implanted hearing devices...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2024
FEED
LISTED
NASDAQ
Envoy Medical Awarded Patent for Recharge System used with Implantable Battery
News Preview
Growing Portfolio of Patents Further Advances the Company’s Mission to Develop Fully Implanted Devices for Those Suffering from Significant Hearing Loss...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.08.2024
FEED
LISTED
NASDAQ
Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update
News Preview
Company continues to make significant progress towards disrupting the existing cochlear implant industry with its investigational, breakthrough fully implanted Acclaim® cochlear implant; Maintains goal of starting Pivotal Clinical Trial by end of the year...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.05.2024
FEED
LISTED
NASDAQ
Envoy Medical Reports First Quarter 2024 Results
News Preview
The Company, a current leader in fully implanted hearing devices, continues to steadily march towards its ambition of disrupting the existing cochlear implant industry with its “breakthrough” fully implanted cochlear implant....
Themefolio
Profiler
Peergroup
© Newsfile
30.01.2024
FEED
LISTED
NASDAQ
Envoy Medical, Inc. to Present at The Microcap Conference
News Preview
White Bear Lake, Minnesota--(Newsfile Corp. - January 30, 2024) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing systems, will be participating in The Microcap Conference, which will take place January 30, 31, February 1, 2024 at Caesars Atlantic City Hotel &...
Themefolio
Profiler
Peergroup
© Newsfile
03.10.2023
FEED
LISTED
NASDAQ
Envoy Medical Announces Participation in the LD Micro Main Event XVI
News Preview
Presentation on Wednesday, October 4th at 1:00 PM PTWhite Bear Lake, Minnesota--(Newsfile Corp. - October 3, 2023) - Envoy Medical Inc. (NASDAQ: COCH), a hearing health company, announced today that it will be presenting an updated corporate overview at the 16th annual Main Event on Wednesday, October 4th at 1:00 PM PT at the Luxe Sunset Boule...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
